| Quote | Spy PSTI NEW ![]() |
Message Board | |||||
|
Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders. |
|
Traders Send Select Stem Cell Shares Soaring
ABT JNJ NBS GILD BCRX GERN NVAX OPXA PSTI CUR OSIR ATHX Linked by tickerspy blog - February 08, 10:30AM from (www.tickerspy.com) The absence of notable news didn't stop speculators in the stem cell sector on Monday. Select stem cell more ...
Analyst Upgrades, Downgrades and Initiations: BBY, EXC, GPS, H, LEAP, MA, MOT, TAP ...
TAP STST GPS MOT JWN HOT MUR BBY MTH PFWD LEAP EXC MA PSTI XEC EDU SOL Linked by BloggingStocks - February 05, 11:40AM from (www.bloggingstocks.com) Analyst Upgrades Wells Fargo upgraded MasterCard (MA) to outperform from market perform on valuation as more ...
Fat Gains for Select Stem Cell Stocks
PFE NBS KOOL STEM GERN OPXA CYTX PSTI CUR ATHX Linked by tickerspy blog - January 08, 11:39AM from (www.tickerspy.com) Cytori Therapeutics (CYTX) led the stem cell sector on Friday. It's been a strong week for select stem more ...
Stem Cell Stocks Rise, Led By Athersys Inc.
PFE NBS KOOL STEM GERN ASTM OPXA CYTX PSTI CUR OSIR ATHX Linked by 24/7 Wall St. - December 21, 02:33PM from (247wallst.com) Stem cell stocks (tracked in Tickerspy's Stem Cell Stock's Index (*RXSTM) are up over 7% today, led by Athersys Inc (NASDAQ: more ...
Stem Cell Stocks Take Off
KOOL NHI STEM GERN ASTM OPXA CYTX PSTI CUR OSIR Linked by 24/7 Wall St. - December 02, 03:35PM from (247wallst.com) Tickerspy's Stem Cell Stock Index (*RSXTM) took off today, rising nearly 13%. The movement followed a release from the National more ...
Can Stem Cells Put an End To Paralysis?
KOOL STEM GERN ASTM OPXA NVS PSTI CUR OSIR Linked by tickerspy blog - November 11, 11:28AM from (www.tickerspy.com) A successful rodent study showed promise for future treatment of spinal injuries. Menlo Park, California-based more ...
Another Coin-Flip Bet on a Stem Cell Drug
ASTM OPXA CYTX PSTI CUR OSIR Linked by tickerspy blog - October 09, 11:13AM from (www.tickerspy.com) The recent pullback in stem cell stocks is testing the 2009 uptrend's support. In September, when the more ...
Stem Cell Summit Can’t Excite Investors
KOOL GERN ASTM OPXA CYTX NVS PSTI CUR OSIR Linked by tickerspy blog - September 30, 01:23PM from (www.tickerspy.com) The 2009 World Stem Cell Summit concluded a week ago, and since then the sector's stocks have slipped into the red. more ...
Investors Won Big in This Week's Top Sectors
OPXA HST CYTX NVS PSTI AHT FSLR SHO DRH SOLF CSIQ TSL JASO Linked by tickerspy blog - September 11, 12:43PM from (www.tickerspy.com) It was a strong September week for the equity markets, especially in these high-flying sectors. After more ...
This 10-Bagger's Still Got Legs
KOOL STEM GERN OPXA CYTX NVS PSTI OSIR Linked by tickerspy blog - September 08, 12:43PM from (www.tickerspy.com) More news from Opexa (OPXA) sent shares higher by 170%. Opexa shares more than doubled on Tuesday more ...
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | About | Register | My tickerspy | Logout | Web site design by LightMix |
| © 2010 Indie Research, LLC. All rights reserved. | |
---
Institutional Holdings Disclaimer Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter. Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time. tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors. THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF.
|
|